tPA by telephone: Extending the benefits of a comprehensive stroke center

被引：55

作者：

Frey, JL

Jahnke, HK

Goslar, PW

Partovi, S

Flaster, MS

机构：

[1] Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA

[2] Barrow Neurol Inst, Dept Clin Res, Phoenix, AZ 85013 USA

[3] Barrow Neurol Inst, Dept Biostat, Phoenix, AZ 85013 USA

[4] Barrow Neurol Inst, Dept Neuroradiol, Phoenix, AZ 85013 USA

来源：

NEUROLOGY | 2005年 / 64卷 / 01期

关键词：

D O I：

10.1212/01.WNL.0000148595.05198.D6

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The use of tissue plasminogen activator (tPA) in community hospitals has been limited by a lack of neurologic support. The authors developed a telephone network to support community emergency departments (EDs) in the use of tPA. Their experience demonstrates equivalent results for patients treated by telephone and those treated in-house. Their number of tPA-treated patients increased 72%. Requirements included willingness of community EDs to use tPA and willingness of the stroke center to provide support.

引用

收藏

页码：154 / 156

页数：3

相关论文

共 10 条

[1] Guidelines for the early management of patients with ischemic stroke - A scientific statement from the Stroke Council of the American Stroke Association [J].

Adams, HP ;

Adams, RJ ;

Brott, T ;

del Zoppo, GJ ;

Furlan, A ;

Goldstein, LB ;

Grubb, RL ;

Higashida, R ;

Kidwell, C ;

Kwiatkowski, TG ;

Marler, JR ;

Hademenos, GJ .

STROKE, 2003, 34 (04) :1056-1083

[2] Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study [J].

Albers, GW ;

Bates, VE ;

Clark, WM ;

Bell, R ;

Verro, P ;

Hamilton, SA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1145-1150

[3] Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility [J].

Barber, PA ;

Zhang, J ;

Demchuk, AM ;

Hill, MD ;

Buchan, AM .

NEUROLOGY, 2001, 56 (08) :1015-1020

[4] Differences in stroke between white, Hispanic, and Native American patients - The Barrow Neurological Institute stroke database [J].

Frey, JL ;

Jahnke, HK ;

Bulfinch, EW .

STROKE, 1998, 29 (01) :29-33

[5] Intravenous tissue-type plasminogen activator therapy for ischemic stroke - Houston experience 1996 to 2000 [J].

Grotta, JC ;

Burgin, WS ;

El-Mitwalli, A ;

Long, M ;

Campbell, M ;

Morgenstern, LB ;

Malkoff, M ;

Alexandrov, AV .

ARCHIVES OF NEUROLOGY, 2001, 58 (12) :2009-2013

[6] Telemedicine for acute stroke - Triumphs and pitfalls [J].

LaMonte, MP ;

Bahouth, MN ;

Hu, P ;

Pathan, MY ;

Yarbrough, KL ;

Gunawardane, R ;

Crarey, P ;

Page, W .

STROKE, 2003, 34 (03) :725-728

[7] Thrombolytic therapy for acute ischemic stroke: Why the majority of patients remain ineligible for treatment [J].

O'Connor, RE ;

McGraw, P ;

Edelsohn, L .

ANNALS OF EMERGENCY MEDICINE, 1999, 33 (01) :9-14

[8] Expanded modes of tissue plasminogen activator delivery in a comprehensive stroke center increases regional acute stroke interventions [J].

Rymer, MM ;

Thurtchley, D ;

Summers, D .

STROKE, 2003, 34 (06) :E58-E60

[9]

SOLOMON RC, 2001, TPA ACUTE ISCHEMIC S

[10] Treating acute stroke patients with intravenous tPA - The OSF Stroke Network experience [J].

Wang, DZ ;

Rose, JA ;

Honings, DS ;

Garwacki, DJ ;

Milbrandt, JC .

STROKE, 2000, 31 (01) :77-81